v3.26.1
Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Significant Accounting Policies [Abstract]  
Schedule of Fair Value Measurements on a Recurring Basis

The Company’s financial assets subject to fair value measurements on a recurring basis and the level of inputs used in such measurements were as follows:

 

   March 31, 2026 
   Level 1   Level 2   Level 3   Fair Value 
Assets*:                
Marketable Securities (see note 3):                
DNA   466    
       -
    
-
    466 
Entera   130    
-
    
-
    130 
Pelthos   3,013    
-
    
-
    3,013 
Nano   17,967    
-
    
-
    17,967 
Nano’s Put options and written Call options, net   
-
    1,356    
-
    1,356 
Investments at fair value (see note 4):                    
Ruby Capital   
-
    
-
    492    492 
Royalty Purchase Agreement   
-
    
-
    2,225    2,225 
Tranche A Note   
-
    
-
    25,214    25,214 
Tranche B Note   
-
    
-
    9,724    9,724 
Warrants Note B   
-
    
-
    254    254 
Investment in Alpha Tau’s warrants (see note 8)   
-
    
-
    12,000    12,000 
Profit Sharing Loan Agreement   
-
    
-
    1,933    1,933 
Loan agreement measured in fair value (see note 7)   
-
    
-
    35,412    35,412 
Investment in Alpha Tau’s shares (see note 8)   102,299    
-
    
-
    102,299 
Loan to an Equity Method Investee (see note 6)   
-
    
-
    423    423 
    $ 123,875     $ 1,356     $ 87,677     $ 212,908  

 

*As to financial instruments related to the transaction with Lifeward refer to note 9.
   December 31, 2025 
   Level 1   Level 2   Level 3   Fair Value 
Assets:                
Marketable Securities (see note 3):                
DNA   540    
      -
    
-
    540 
Entera   227    
-
    
-
    227 
Pelthos   4,650    
-
    
-
    4,650 
Nano   8,371    
-
    
-
    8,371 
Investments at fair value (see note 4):                    
Royalty Purchase Agreement   
-
    
-
    2,209    2,209 
Tranche A Note   
-
    
-
    23,063    23,063 
Warrants Note B   
-
    
-
    850    850 
Tranche B Note   
-
    
-
    11,473    11,473 
Loan agreement measured in fair value (see note 7)   
-
    
-
    27,943    27,943 
Investment in Alpha Tau’s warrants (see note 8)   
-
    
-
    6,242    6,242 
Profit Sharing Loan Agreement   
-
    
-
    1,890    1,890 
Investment in Alpha Tau’s shares (see note 8)   71,623    
-
    
-
    71,623 
Loan to an equity method investee (see note 6)   
-
    
-
    553    553 
Convertible note (see note 9)   
-
    
-
    4,636    4,636 
   $85,411   $
-
   $78,859   $164,270